Ambulatory Services Market Research Report 2018 Analysis and Forecast to 2023

Market Scenario:

The global ambulatory services market is a continuously growing market and will grow at similar rate in coming future. The global ambulatory services market is expected to reach USD 3365.2 billion by 2022 from USD 2345.7 billion in 2016 with a CAGR of 5.1% for the forecasted period. Ambulatory services provides convenient and cost-effective services to the patient. It is also called as outpatient care which provides the various medical facilities like diagnosis, counselling, observation and also treatment. Ambulatory services market is driven by various factors like continuously ameliorating aging population, easy in-access, cost-effective and by various government initiatives and funding. Increase in life expectancy is a crucial reason to provide the services for disable and frailties ultimately led to increasing growth in this market.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/2491

Segments:                                                                                                                                        

Global Ambulatory Services market has been segmented on the basis of service type which comprises of primary care offices, medical specialty, ambulatory surgery, outpatient departments (OPDs) and emergency departments. On the basis of region, the market is segmented into North America, Europe, Asia Pacific and MEA.

Key Players for Ambulatory Services Market:                                             

Some of the key players in this market are: AmSurg Corp, Surgical Care Affiliates, Surgery Partners, HCA Holdings, Inc, Healthway Medical Group, SurgCenter, Trillium Health Partners.  

Key Findings

• North America accounted for the largest market share with 41.2% of the global Ambulatory Services market in the year 2016.
• Primary care offices market holds the largest market share by service type.
• Ambulatory surgeries is the fastest growing segment at CAGR of 5.5% from 2017 to 2022.
• Asia-Pacific pacific projected to be the fastest growing region with a growth rate of 5.5% for the forecasted period.

Regional Analysis of Ambulatory Services Market:                                               

North America is the largest market of global ambulatory services market which is expected to grow at the CAGR of 4.8%. The largest market share of ambulatory services is attributed due to various factors including specialized technique available for the patients, presence of large number of ambulatory centers, solid support from the government and various organizations, high patient fulfilment with high quality and low cost services. Moreover with the presence of well-established players like AMSURG, Surgical Care Affiliates, Surgery Partners, HCA Holdings, Inc in United Sates is boosting the market. These players are expanding their network with other healthcare providers and physicians to enhance their presence and further enhancing the market.

Europe is the second largest market for ambulatory services which is expected to grow at a CAGR of 5.3%.

Globally Asia-Pacific market is expected to be the fastest growing market. This high growth is mainly attributed due to increasing funding and growing infrastructure by the developing countries like China and India for the development of healthcare sector.

       

Browse Complete 67 Pages Premium Research Report Enabled with Respective Tables and Figures at @ https://www.marketresearchfuture.com/reports/ambulatory-services-market-2491

Table Of Contents

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Treatment Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

5.1.2 Bargaining Power Of Buyers

5.1.3 Threat Of New Entrants

5.1.4 Threat Of Substitutes

5.1.5 Intensity Of Rivalry

...Continued

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Lung Cancer Market Share, Opportunities, Segmentation and Forecast to 2023

The Lung cancer Market is growing mainly due to the changing lifestyle, and environmental pollution. According to a recent study report published by the Market Research Future, The lung cancer market is booming and expected to gain prominence over the forecast period. The market is forecasted to demonstrate a spectacular growth by 2023, surpassing its previous growth records in terms of value with a striking CAGR of 13.5% during the anticipated period (2017 – 2023).

Get Reports Sample Copy @ https://www.marketresearchfuture.com/sample_request/1185

Lung cancer is a malignant lung tumor characterized by uncontrolled cell growth in lung tissue with symptoms such as coughing, weight loss, and fatigue and chest pain. The two types of lung cancers are small-cell lung cancer (SCLC) and non-small-cell lung cancer (NSCLC). The NSCLC type accounts for almost 80% of the total lung cancers. The cure rates for the two types of lung cancers exchange their positions with the SCLC being the most malignant. The cure rates also depend on the stage of cancer detection with rates varying by 55% for first stage to just 1% for stage four.

Almost 85% of cases of lung cancer are due to long-term tobacco smoking. Cigarette smoke contains at least 73 known carcinogens. Other factors causing lung cancer are genetic factors and exposure to triggers and carcinogens such as radon gas, asbestos, radioactive materials, second-hand smoke, or air pollution. It has also been demonstrated that passive smokers have a 20–30% increase in risk.

The treatments for lung cancer include surgery, chemotherapy, and radiotherapy with NSCLC responding better to surgery and SCLC usually responding better to chemotherapy and radiotherapy. Notably, smoking is the primary driver for the rising cases of lung cancer. According to World Health Organization (WHO) tobacco kills more than 7 million people each year of which more than 6 million deaths are the result of direct tobacco use. Lung cancer is the leader with a whopping 37% of deaths. Of more concern is the rising rates of lung cancer due to passive smoking.

Other push factors such as, environmental pollution, rising cases of infections, growing rates of early detection and awareness, rising rates of fast growing lung cancer, and reimbursements and growing health insurance are also fuelling the growth of the market.

Despite these drivers, poor efficacy, cure rates and side effects of present treatment, high failure rates of lung transplant surgeries, high malignant nature and faster growth of lung cancer, poor life expectancy and quality of life of patients undergoing lung cancer treatment, and scarcity of lung organ and long waiting lines are expected to decline the market growth. According to American Society of Clinical Oncology (ASCO) the 5-year survival rate for stage I NSCLC is about 47% which falls drastically to 10% for stage III. The 5-year survival rate for stage IV NSCLC is just around 1%.

Key Players for Global Lung Cancer Market: 

·         F. Hoffmann-La Roche AG

·         Novartis

·         PFIZER INC

·         Merck & Co., Inc.

·         BRISTOL-MYERS SQUIBB

·         ELI Lilly and Company

·         Sanofi

Segments:

Global Lung Cancer Market has been segmented on the basis of types which comprises of SCLC and NSCLC. On the basis of treatments it is segmented into Surgery, Chemotherapy, Radiotherapy, Photodynamic therapy (PDT) and Laser therapy. On the basis of end users, it includes Hospitals & Clinics, Cancer Research Centers and Laboratories.

Regional Analysis:

The global market for Lung Cancer is growing steadily. The global lung cancer market on the basis of region comprises of North America, Europe, Asia Pacific and Middle East & Africa. The global market for Lung Cancer is growing with the CAGR of 13.5% during the forecast period from 2017-2023. NSCLC is the most common type of lung cancer globally. The global Lung Cancer market reached USD 36929.8 million in 2023 from 15219.7 million in 2016. Europe region captured the second largest market globally and is expected to reach USD 8,536.3 million by 2023 due to the growing demand and need for lung cancer drugs, and the growing prevalence of lung cancer.

Browse Complete 108  Pages Premium Research Report Enabled with 121 Respective Tables and Figures at @ https://www.marketresearchfuture.com/reports/lung-cancer-market-1185

Detailed Table Of Contents

1 Report Prologue

2 Introduction

2.1 Research Objective

2.2 Assumptions & Limitations

2.2.1 Assumptions

2.2.2 Limitations

2.3 Market Structure

3 Research Methodology

3.1 Primary Research

3.2 Secondary Research

4   Porters Five Forces

4.1 Introduction

4.2 Bargaining Power Of Buyer

4.3 Bargaining Power Of Suppliers

4.3.1 Threat From Substitute

4.3.2 Threat From A New Entrant

4.3.3 Intensity Of Competitive Rivalry

5 Market Dynamics

5.1 Drivers

5.1.1 Smoking

5.1.2 Environmental Pollution

5.1.3 Rising Cases Of Infections

5.1.4 Growing Rates Of Early Detection And Awareness

5.1.5 Rising Rates Of Fast Growing Lung Cancer

5.1.6 Reimbursements And Growing Health Insurance

...Continued

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Osteoporosis Drugs Market Dynamics, Forecast, Analysis and Supply Demand 2018

Osteoporosis is weakening of bones due to lower bone mass resulting in and micro-architectural deterioration of bone tissue and subsequent higher risk of a broken fracture. It generally occurs at an advanced age and women are more susceptible to it than males by about three to four folds. WHO estimates that around 1.66 million hip fractures occur each year worldwide due to osteoporosis. According to national osteoporosis foundation about 54 million Americans suffer from osteoporosis.

The disease also has a genetic bias in that it Caucasians are more affected than Asians. The disease prevalence is lowest in African population.

Get Sample Report @ https://www.marketresearchfuture.com/sample_request/2479

The market driving factors were identified to be rise in the geriatric population, increased screening, drug induced osteoporosis, alcoholism and smoking, increased awareness and focus towards female health, rising prevalence of diseases, conditions and medical procedures that may cause bone loss such as cancer, autoimmune disorders, thalassemia, hormonal disorders, modern lifestyle etc.

The market restraints are loss of patents of block busters, greater penetration of generics and fragmentation of market, poor efficacy and side effects of present therapies, non-life threatening nature and poor symptoms of osteoporosis etc.

Taking all the factors into consideration, we expect the global osteoporosis market which totaled ~ $10,855 million to reach 14,300 million by 2022, growing with a CAGR of 4.7%.

Key Players:

Eli Lilly and Company

Merck & Co.

Novartis International AG

Amgen Inc.

F. Hoffmann La Roche Ltd.

Pfizer Inc.

Novo Nordisk

Teva Pharmaceutical Industries Ltd

Segmentation:
Global osteoporosis drugs market has been segmented on the basis of drug class which comprises bisphosphonates, calcitonin’s, selective estrogen receptor modulators (SERMS), parathyroid hormone (PTH) and others. On the basis of route of administration; market is segmented into oral, injectable and others. On the basis of gender the market is segmented into male and female.

Regional Analysis
Globally America is the largest market for osteoporosis drugs. Europe is the second-largest market for osteoporosis drugs. The developed regions are expected to hold their market leadership in the near future but with falling market share due to rise of Asia Pacific region which is expected to be fastest growing region in osteoporosis drugs market. The Asia pacific region will be led by China and India. Africa is expected to be a laggard in the global osteoporosis market.

Browse Complete 84 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/osteoporosis-drugs-market-2479

Detailed Table of Contents:

1 Introduction

1.1 Definition

1.2 Scope Of Study

1.3 Research Objective

1.4 Assumptions & Limitations

1.5 Market Structure

2 Research Methodology

2.1 Research Process

2.2 Primary Research

2.3 Secondary Research

3 Market Dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Challenges

3.5 Macroeconomic Indicators

4 Market Factor Analysis

4.1 Porter’s Five Forces Model

4.1.1 Bargaining Power Of Suppliers

4.1.2 Bargaining Power Of Customer

4.1.3 Intensity Of Competitor’s

4.1.4 Threat Of New Entrants

5 Global Osteoporosis Drugs Market, By Drug Class

5.1 Introduction

5.2 Bisphosphonates

5.3 Calcitonins

5.4 Selective Estrogen Receptor Modulators (SERMs)

5.5 Parathyroid Hormone (PTH

5.6 Others

...Continued

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Anti-Viral Drugs Market 2018 Share, Trend, Segmentation and Forecast to 2023

Market Synopsis of Global Anti-Viral Drugs Market:
Market Scenario:
Viruses are the ultimate parasites as they derive nutrition from the host cell and also hijack and direct its metabolic machinery to synthesize new virus particles. Viruses can live and replicate only inside host body. Anti-viral drugs are specifically used to treat viral infections and act mostly by inhibiting their target viruses. The growth of antiviral drugs market is driven by factors such as rise in healthcare expenditure, growing research and development investment, emergence of virus life-threatening diseases like bird flu, strong development pipeline and increasing incidence rates of viral infections particularly HIV. WHO estimates 36.7 million people are suffering from HIV/AIDS worldwide with 1.1 million deaths of AIDS-related illnesses in 2015.
Taking all these factors the market for anti-viral drugs is expected to reach $62.67 billion by the end of the forecast period growing at a CAGR of 6.9%.
Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/2454
Intended Audience

• Anti-viral drugs Manufacturers
• Anti-viral drugs Suppliers
• Private Research Laboratories
• Research and Development (R&D) Companies
• Market Research and Consulting Service Providers
• Government Research Laboratories
• Contract Manufacturing Organizations

Key Players for Global Anti-Viral Drugs Market:
Some of the key players in this market are: Johnson & Johnson, Merck & Co. Inc., Gilead Sciences Inc., Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Abbott Laboratories, Novartis International AG, Astra Zeneca AB, Cipla Inc.
Market Segments:
Global Anti-viral drugs market has been segmented on the basis of application, which comprises hepatitis, HIV/AIDS, herpes, influenza and others. On the basis of mechanism of action; market is segmented into nucleotide polymerase inhibitors, reverse transcriptase inhibitors, protease inhibitors and others.
Regional Analysis of Global Anti-Viral Drugs Market:
Globally America is the largest market for anti-viral drugs. North America dominated the market for anti-viral drugs with a share of greater than 30%.  Europe is the second-largest market for anti-viral drugs. Asia pacific region is expected to be fastest growing region in anti-viral drugs market.
Browse Complete 84 Pages Premium Research Report Enabled with Respective Tables and Figures at @ https://www.marketresearchfuture.com/reports/anti-viral-drugs-market-2454
Table Of Contents
1 Introduction
1.1 Definition
1.2 Scope Of Study
1.3 Research Objective
1.4 Assumptions & Limitations
1.5 Market Structure:
2 Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
3 Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
3.5 Macroeconomic Indicators
4 Market Factor Analysis
4.1 Porter’s Five Forces Model
4.1.1 Bargaining Power Of Suppliers
4.1.2 Bargaining Power Of Customer
4.1.3 Intensity Of Competitor’s
4.1.4 Threat Of New Entrants
...Continued



About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com